FASTKD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.069600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.093000E-01
Normal-vs-Stage2
3.867800E-01
Normal-vs-Stage3
7.140000E-02
Normal-vs-Stage4
9.064600E-01
Stage1-vs-Stage2
9.874400E-01
Stage1-vs-Stage3
8.257800E-02
Stage1-vs-Stage4
2.956800E-01
Stage2-vs-Stage3
5.995700E-02
Stage2-vs-Stage4
2.395800E-01
Stage3-vs-Stage4
4.164100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.249000E-01
Normal-vs-AfricanAmerican
3.244400E-01
Normal-vs-Asian
5.112600E-01
Caucasian-vs-AfricanAmerican
5.820200E-01
Caucasian-vs-Asian
8.936600E-01
AfricanAmerican-vs-Asian
7.431800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.072200E-01
Normal-vs-Female
3.132800E-01
Male-vs-Female
2.633000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.340200E-01
Normal-vs-Age(41-60Yrs)
3.891200E-01
Normal-vs-Age(61-80Yrs)
4.303600E-01
Normal-vs-Age(81-100Yrs)
5.149400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.798600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.359200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.956600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.252200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.543400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.691000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.534380E-01
Normal-vs-Daily Drinker
2.109600E-01
Normal-vs-Weekly Drinker
3.076200E-01
Normal-vs-Occasional Drinker
5.973800E-01
Normal-vs-Social Drinker
6.179200E-01
Non Drinker-vs-Daily Drinker
7.510400E-01
Non Drinker-vs-Weekly Drinker
3.800800E-01
Non Drinker-vs-Occasional Drinker
5.605500E-02
Non Drinker-vs-Social Drinker
1.404610E-01
Daily Drinker-vs-Weekly Drinker
5.709400E-01
Daily Drinker-vs-Occasional Drinker
1.268030E-01
Daily Drinker-vs-Social Drinker
2.555200E-01
Weekly Drinker-vs-Occasional Drinker
3.711600E-01
Weekly Drinker-vs-Social Drinker
5.591800E-01
Occasional Drinker-vs-Social Drinker
8.671600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.496850E-01
Normal-vs-Grade 2
4.679900E-02
Normal-vs-Grade 3
6.224400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.998600E-01
Grade 1-vs-Grade 3
4.808000E-01
Grade 1-vs-Grade 4
1.496850E-01
Grade 2-vs-Grade 3
6.932000E-01
Grade 2-vs-Grade 4
4.679900E-02
Grade 3-vs-Grade 4
6.224400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.292400E-01
Normal-vs-NonDiabetic
3.868200E-01
Diabetic-vs-NonDiabetic
5.085000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.388220E-01
Normal-vs-NoPancreatitis
3.856800E-01
Pancreatitis-vs-NoPancreatitis
3.779800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.438800E-01
Normal-vs-N1
3.696800E-01
N0-vs-N1
4.307600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.327200E-01
Normal-vs-TP53-NonMutant
6.912400E-01
TP53-Mutant-vs-TP53-NonMutant
9.240000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
